154 related articles for article (PubMed ID: 36150349)
1. Risk of appendicitis associated with the use of clozapine: A pharmacovigilance study.
Uwai Y; Nabekura T
Asian J Psychiatr; 2022 Nov; 77():103264. PubMed ID: 36150349
[No Abstract] [Full Text] [Related]
2. Appendicitis Associated With Clozapine: Analyses Based on a Spontaneous Reporting System Database in Japan.
Misawa F; Nakajima N; Fujii Y; Takeuchi H
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):228-232. PubMed ID: 36999743
[TBL] [Abstract][Full Text] [Related]
3. Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions.
De Leon J; Sanz EJ; De Las Cuevas C
Schizophr Bull; 2020 Jan; 46(1):1-3. PubMed ID: 31901099
[No Abstract] [Full Text] [Related]
4. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia).
De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():165-174. PubMed ID: 37301669
[TBL] [Abstract][Full Text] [Related]
5. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.
Sagud M; Breznoscakova D; Celofiga A; Chihai J; Chkonia E; Ristic Ignjatovic D; Injac Stevovic L; Kopecek M; Kurvits K; Kuzo N; Lazáry J; Mazaliauskienė R; Mladina Perisa D; Novotni A; Panov G; Pikirenia U; Rădulescu FȘ; Sukiasyan SG; Taube M; Tomori S; Wilkowska A; De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():53-59. PubMed ID: 37783650
[TBL] [Abstract][Full Text] [Related]
6. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
7. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
8. According to the WHO clozapine pharmacovigilance database, the United Kingdom accounts for 968 fatal outcomes versus 892 in the rest of the world.
de Leon J
Br J Clin Pharmacol; 2022 Dec; 88(12):5434-5435. PubMed ID: 36106607
[No Abstract] [Full Text] [Related]
9. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.
De Las Cuevas C; Sanz EJ; Gross JA; Correll CU; Verdoux H; Lally J; de Filippis R; Schulte PFJ; Molden E; Arrojo-Romero M; Bostrom AD; Schoretsanitis G; Fernandez-Egea E; de Leon J
Schizophr Res; 2024 Jun; 268():175-188. PubMed ID: 38065799
[TBL] [Abstract][Full Text] [Related]
10. A national pharmacovigilance study of haematological adverse drug reactions to clozapine vs other second-generation antipsychotics in Italy.
Bertoli S; Casetta C; Giordano B; D'Agostino A
Schizophr Res; 2023 Jul; 257():25-26. PubMed ID: 37244166
[No Abstract] [Full Text] [Related]
11. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
12. Medications and the risk of perforated appendicitis: an adverse event report system (FAERS) database analysis.
Ramai D; Mozell D; Facciorusso A; Kewalramani A; Chandan S; Dhindsa B; Dhaliwal A; Khan S; Adler DG
Expert Rev Gastroenterol Hepatol; 2022 Oct; 16(10):1011-1017. PubMed ID: 36322707
[TBL] [Abstract][Full Text] [Related]
13. Is the higher incidence of clozapine induced myocarditis in Australia due to awareness and monitoring?
Dawson JL; Clark SR; Sluggett JK; Procter NG; Bell JS
Schizophr Res; 2018 Nov; 201():426-427. PubMed ID: 29907491
[No Abstract] [Full Text] [Related]
14. Analysis of Appendicitis Cases in the Japanese Adverse Drug Event Report (JADER) Database.
Kyotani Y; Zhao J; Nakahira K; Yoshizumi M
Biol Pharm Bull; 2023; 46(5):655-660. PubMed ID: 37121692
[TBL] [Abstract][Full Text] [Related]
15. Six Cases of Perforated Appendicitis During Clozapine Treatment.
Steinert T; Jans F
J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34166590
[No Abstract] [Full Text] [Related]
16. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
Liu CL; Maruf AA; Bousman CA
Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
[TBL] [Abstract][Full Text] [Related]
17. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance.
Baptista T; Motuca M; Serrano A; Perez Lo Presti A; Fernandez-Arana A; Olmos I; Pabon A; Yepez JGA; Alejo Galarza GJ; Rivera Ramirez NM; Elkis H; Sanz EJ; De Las Cuevas C; de Leon J
Schizophr Res; 2024 Jun; 268():60-65. PubMed ID: 37985318
[TBL] [Abstract][Full Text] [Related]
18. Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies.
Koutkias VG; Lillo-Le Louët A; Jaulent MC
Expert Opin Drug Saf; 2017 Feb; 16(2):113-124. PubMed ID: 27813420
[TBL] [Abstract][Full Text] [Related]
19. Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database.
Hatano M; Kamei H; Shimato A; Yamada S; Iwata N
Psychiatry Res; 2020 Sep; 291():113249. PubMed ID: 32603929
[TBL] [Abstract][Full Text] [Related]
20. Safety of pitolisant: a study in the WHO international pharmacovigilance database.
Montastruc JL
Eur J Clin Pharmacol; 2023 Apr; 79(4):569-570. PubMed ID: 36892631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
